Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Cancer Biology and the Nuclear Envelope: Recent Advances May Elucidate Past Paradoxes

by Eric C. Schirmer
Save 35% Save 35%
Current price ₹14,534.00
Original price ₹22,359.00
Original price ₹22,359.00
Original price ₹22,359.00
(-35%)
₹14,534.00
Current price ₹14,534.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9781489980311
  • Binding: Hardcover
  • Subject: N/A
  • Publisher: Springer
  • Publisher Imprint: Springer
  • Publication Date:
  • Pages: 611
  • Original Price: EUR 199.99
  • Language: English
  • Edition: 2014
  • Item Weight: 1339 grams
  • BISAC Subject(s): Oncology / General, Microbiology, and Life Sciences / Biochemistry

From the Back Cover

"Nuclear envelope (NE) defects have been linked to cancer biology since the mid-1800s, but it was not until the last few years that we have begun to understand these historical links and to realize that there are myriad ways that the NE impacts on tumorigenesis. The NE is a complex double membrane system that encloses the genome while providing structural support through the intermediate filament lamin polymer and regulating protein/ mRNA trafficking and signaling between the nucleus and cytoplasm via the nuclear pore complexes (NPCs). These functions already provide some mechanisms for NE influences on cancer biology, but work in the past few years has elucidated many others. Lamins and many recently identified NE transmembrane proteins (NETs) have been now shown to function in DNA repair, regulation of cell cycle and signaling, apoptosis, cell migration in metastasis, and nuclear architecture and morphology.
This volume presents a comprehensive overview of the wide range of functions recently identified for NE proteins and their relevance in cancer biology, providing molecular mechanisms and evidence of their value as prognostic and diagnostic markers, and suggesting new avenues for the treatment of cancer. Indeed some of these recent links are already yielding promising therapies, such as the current clinical trial of selective inhibitors of the nuclear export factor exportin in certain types of leukemia, melanoma and kidney cancer."

Eric C. Schirmer, Ph.D., Wellcome Trust Senior Research Fellow, Wellcome Trust Centre for Cell Biology and Reader, Institute of Cell Biology at the University of Edinburgh. Jose de las Heras Ph.D., Researcher at the University of Edinburgh.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us